Lv69
3060 积分 2022-03-25 加入
In vivo CAR-Ts captivate big pharma
1天前
已完结
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
2天前
已完结
Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor
11天前
已完结
CDK inhibitors from past to present: A new wave of cancer therapy
13天前
已完结
BBO-10203 inhibits tumor growth without inducing hyperglycemia by blocking RAS-PI3Kα interaction
1个月前
已完结
Discovery of Fulzerasib (GFH925) for the Treatment of KRAS G12C-Mutated Solid Tumors
1个月前
已完结
Screening assays for tyrosine kinase inhibitors: A review
1个月前
已完结
CDK4 and CDK6 kinases: From basic science to cancer therapy
1个月前
已完结
The RB protein: more than a sentry of cell cycle entry
1个月前
已完结
Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future
2个月前
已完结
皖公网安备34019202002308
